Topics

Dova's avatrombopag for thrombocytopenia gains orphan drug tag

04:59 EST 14 Jan 2020 | SmartBrief

The FDA granted Dova Pharmaceuticals' candidate Doptelet, or avatrombopag, orphan drug designation as a treatment for chemoth -More

Original Article: Dova's avatrombopag for thrombocytopenia gains orphan drug tag

NEXT ARTICLE

More From BioPortfolio on "Dova's avatrombopag for thrombocytopenia gains orphan drug tag"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...